[2R]-2-(4-METHOXYPHENYL)-[1, 3] DIOXAN-4-YL methanol | 815600-23-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: [2R]-2-(4-METHOXYPHENYL)-[1, 3] DIOXAN-4-YL methanol
• 英文别名: [(4R)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl]methanol
• CAS: 815600-23-8
• 化学式: C₁₂H₁₆O₄
• 分子量: 224.257
• InChiKey: WWQMKMCPEHHJGY-JHJMLUEUSA-N

物化性质

• 沸点：
  369.9±37.0 °C(Predicted)
• 密度：
  1.148±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  47.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  [2R]-2-(4-METHOXYPHENYL)-[1, 3] DIOXAN-4-YL methanol 在 咪唑 、 sodium hydride 、 二异丁基氢化铝 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 26.0h， 生成 tert-Butyl-[(R)-3-(4-methoxy-benzyloxy)-1-methoxymethyl-propoxy]-dimethyl-silane
  参考文献：
  名称：

  细胞凋亡素的合成研究：通过高度立体选择性羟醛反应合成C12–C28片段

  摘要：

  描述了细胞凋亡诱导大环内酯类抗生素细胞凋亡素（1）的C12–C28片段2的立体选择性和会聚性。合成过程涉及C17–C22乙基酮3与C23–C28醛4之间的高度立体选择性锡（II）介导的羟醛反应，这是关键步骤。

  DOI：

  10.1016/j.tetlet.2004.09.177
• 作为产物：
  描述：

  (R)-(+)-1,2,4-丁三醇 、 4-甲氧基苯甲醛 在 4-甲基苯磺酸吡啶 作用下， 以 苯 为溶剂， 反应 10.0h， 以65%的产率得到[2R]-2-(4-METHOXYPHENYL)-[1, 3] DIOXAN-4-YL methanol
  参考文献：
  名称：

  [EN] ANALOGS OF DISCODERMOLIDE AND DICTYOSTATIN-1, INTERMEDIATES THEREFOR AND METHODS OF SYNTHESIS THEREOF
  [FR] ANALOGUES DE DISCODERMOLIDE ET DE DICTYOSTATINE-1, INTERMEDIAIRES CORRESPONDANTS, ET PROCEDES DE SYNTHESE CORRESPONDANTS

  摘要：

  以下是该结构的化合物：其中R1为H、烷基基团、芳基、烯基基团、炔基基团或卤素原子；R2为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe；Ra、Rb和Rc独立地为烷基基团或芳基；Rd为烷基基团、芳基、烷氧基烷基团、-RiSiRaRbRc或苄基，其中Ri为烷基烷基团；Re为烷基基团、烯丙基基团、苄基、芳基、烷氧基或-NRgRh，其中Rg和Rh独立地为H、烷基基团或芳基；R3为(CH2)n，其中n为0到5范围内的整数，-CH2CH(CH3)-、-CH=CH-、-CH=C(CH3)-或-C=-C-；R4为(CH2)p，其中p为4到12范围内的整数，-(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-、-(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-，其中y1和y2为1，y3、y4和y5独立地为0或1，Rk1、Rk2、Rk3、Rk4和Rk5独立地为H、CH3或OR2a，Rs1、Rs2、Rs3和Rs4独立地为H或CH3，其中R2a为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe；R5为H或OR2b，其中R2b为H、烷基基团、芳基、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe；前提是该化合物不是dictyostatin 1。

  公开号：

  WO2004022552A1

文献信息

• Novel Synthesis of Stagonolide-F, Putaminoxin and Aspinolide-A
  作者：Ahmed Kamal、Papagari Venkat Reddy、Moku Balakrishna、Singaraboina Prabhakar

  DOI：10.2174/157017811794697502

  日期：2011.2.1

  Novel synthesis of putaminoxin, stagonolide-F and aspinolide-A have been achieved by utilizing (S) and (R)- malic acid. The key feature of the synthetic strategy includes Horner-Wittig olefination, double bond reduction and Steglich esterification. Olefinic acid for putaminoxin and stagonolide-F was prepared from (S)-malic acid whereas olefinic acid for aspinolide-A was prepared from (R)-malic acid and olefinic alcohols for putaminoxin, stagonolide-F and aspinolide-A were prepared by using Browns asymmetric allylboration.

  通过利用（S）和（R）-苹果酸，实现了普他米诺辛、芪内酯-F 和芪内酯-A 的新合成。合成策略的主要特点包括霍纳-维蒂希烯化、双键还原和斯特利希酯化。使用布朗不对称烯丙基硼化法制备了普他米诺辛和拮抗内酯-F 的烯烃酸，而使用(R)-苹果酸制备了阿斯匹灵-A 的烯烃酸，并制备了普他米诺辛、拮抗内酯-F 和阿斯匹灵-A 的烯烃醇。
• Synthesis of the Apoptosis Inducing Agent Apoptolidin. Assembly of the C(16)−C(28) Fragment
  作者：Gary A. Sulikowski、Wai-Man Lee、Bohan Jin、Bin Wu

  DOI：10.1021/ol005769v

  日期：2000.5.1

  [reaction--see text] A stereoselective synthesis of the C(16)-C(28) fragment of the apoptosis inducing agent apoptolidin is described. Key steps include two propionate aldol reactions and a stereoselective Mukaiyama aldol addition of enolsilane 19 to beta-methoxy aldehyde 4.

  [反应-见正文]描述了细胞凋亡诱导剂细胞凋亡素C（16）-C（28）片段的立体选择性合成。关键步骤包括两个丙酸酯羟醛反应和将烯醇硅烷19立体选择性地向Mukaiyama羟醛加成到β-甲氧基醛4中。
• Synthetic studies on apoptolidin: synthesis of the C12–C28 fragment via a highly stereoselective aldol reaction
  作者：Kazuyuki Abe、Koji Kato、Tadamasa Arai、Mohammad Abdur Rahim、Israt Sultana、Shuichi Matsumura、Kazunobu Toshima

  DOI：10.1016/j.tetlet.2004.09.177

  日期：2004.11

  The stereoselective and convergent synthesis of the C12–C28 segment 2 of the apoptosis inducing macrolide antibiotic, apoptolidin (1), is described. The synthesis involves a highly stereoselective tin(II)-mediated aldol reaction between the C17–C22 ethyl ketone 3 and the C23–C28 aldehyde 4 as the key step.

  描述了细胞凋亡诱导大环内酯类抗生素细胞凋亡素（1）的C12–C28片段2的立体选择性和会聚性。合成过程涉及C17–C22乙基酮3与C23–C28醛4之间的高度立体选择性锡（II）介导的羟醛反应，这是关键步骤。
• [EN] ANALOGS OF DISCODERMOLIDE AND DICTYOSTATIN-1, INTERMEDIATES THEREFOR AND METHODS OF SYNTHESIS THEREOF<br/>[FR] ANALOGUES DE DISCODERMOLIDE ET DE DICTYOSTATINE-1, INTERMEDIAIRES CORRESPONDANTS, ET PROCEDES DE SYNTHESE CORRESPONDANTS
  申请人：UNIV PITTSBURGH

  公开号：WO2004022552A1

  公开（公告）日：2004-03-18

  A compound of the following structure: wherein R1 is H, an alkyl group, an aryl group, an alkenyl group, an alkynyl group, or a halogen atom; R2 is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; Ra, Rb and Rc are independently an alkyl group or an aryl group; Rd is an alkyl group, an aryl group, an alkoxylalkyl group, -RiSiRaRbRc or a benzyl group, wherein Ri is an alkylene group; Re is an alkyl group, an allyl group, a benzyl group, an aryl group, an alkoxy group, or -NRgRh, wherein Rg and Rh are independently H, an alkyl group or an aryl group; R3 is (CH2)n where n is and integer in the range of 0 to 5, -CH2CH(CH3)-, -CH=CH-, -CH=C(CH3)-, or -C=-C-; R4 is (CH2)p where p is an integer in the range of 4 to 12, -(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-, -(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-, wherein y1 and y2 are 1 and y3, y4 and y5 are independently 0 or 1, Rk1, Rk2, Rk3, Rk4 and Rk5 are independently H, CH3, or OR2a, and Rs1, Rs2, Rs3, and Rs4 are independently H or CH3, wherein R2a is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; and R5 is H or OR2b, wherein R2b is H, an alkyl group, an aryl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; provided that the compound is not dictyostatin 1.

  以下是该结构的化合物：其中R1为H、烷基基团、芳基、烯基基团、炔基基团或卤素原子；R2为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe；Ra、Rb和Rc独立地为烷基基团或芳基；Rd为烷基基团、芳基、烷氧基烷基团、-RiSiRaRbRc或苄基，其中Ri为烷基烷基团；Re为烷基基团、烯丙基基团、苄基、芳基、烷氧基或-NRgRh，其中Rg和Rh独立地为H、烷基基团或芳基；R3为(CH2)n，其中n为0到5范围内的整数，-CH2CH(CH3)-、-CH=CH-、-CH=C(CH3)-或-C=-C-；R4为(CH2)p，其中p为4到12范围内的整数，-(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-、-(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-，其中y1和y2为1，y3、y4和y5独立地为0或1，Rk1、Rk2、Rk3、Rk4和Rk5独立地为H、CH3或OR2a，Rs1、Rs2、Rs3和Rs4独立地为H或CH3，其中R2a为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe；R5为H或OR2b，其中R2b为H、烷基基团、芳基、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe；前提是该化合物不是dictyostatin 1。